DBV Technologies Alternatives & Competitors
12 companies similar to DBV Technologies — On a mission to advance epicutaneous immunotherapy using our innovative technolo...
Companies similar to DBV Technologies
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Paris, France
Palatin Technologies
We discover and develop novel therapeutics for patients living with inflammatory and autoi...
Immunaeon
Connecting Today's Science to Tomorrow's Cures
Buffalo, United States
SFA Therapeutics
A New Paradigm in Drug Development
Jenkintown, United States
Rival Readout
Competing with DBV Technologies? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Alpine Immune Sciences, Inc.
Leading the Next Evolution of Immunotherapies
Seattle, United States
Allakos Inc
Antibody-based therapeutics to treat various allergies and diseases
Redwood City, United Stat...
ZaBeCor Pharmaceuticals
Pioneering molecular advancements for asthma, allergies, and a spectrum of inflammatory an...
-logo.jpg "VBL Therapeutics (Nasdaq:VBLT)"){kind=logo}
VBL Therapeutics (Nasdaq:VBLT)
Engineering the future of targeted medicines, breaking barriers to develop the next genera...
Israel
Melbourne, Australia
Minneapolis, United State...
VentiRx Pharmaceuticals
Advancing healthcare innovations with targeted therapies for cancer, respiratory, and auto...
Promedior
Pioneering advanced therapies to heal fibrotic and inflammatory diseases at their source,...
About DBV Technologies
DBV Technologies is a global clinical stage biopharmaceutical company founded in 2002 by pediatricians who envisioned the safe and effective treatment of food allergies. The company is headquartered in France and is dedicated to advancing epicutaneous immunotherapy using their innovative technology platform, Viaskin™,...
Development and clinical trials of epicutaneous immunotherapy for food allergies and immunological diseases
Patients with food allergies and other immunological diseases, healthcare providers, investors
Epicutaneous Immunotherapy, Viaskin Technology, Biopharmaceutical Research, Treatment Development, Immunologic Diseases, Pediatric Allergies, Autoimmune Disease Therapies, Inflammatory Disease Treatments, Clinical Stage Research, Peanut Allergy Treatment, Immunotherapy Innovations
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around DBV Technologies: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at DBV Technologies on 7 Jun 2025. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
